Results 21 to 30 of about 623,470 (191)

POEMS syndrome: Update on diagnosis, risk‐stratification, and management

American Journal of Hematology, Volume 98, Issue 12, Page 1934-1950, December 2023., 2023
Abstract Disease Overview POEMS syndrome is a life‐threatening condition due to an underlying plasma cell neoplasm. The major criteria for the syndrome are polyradiculoneuropathy, clonal plasma cell disorder, sclerotic bone lesions, elevated vascular endothelial growth factor, and the presence of Castleman disease.
Angela Dispenzieri
wiley   +1 more source

Transformation of HHV‐8‐negative idiopathic multicentric Castleman disease into diffuse large B‐cell lymphoma: A case report from Nepal

Clinical Case Reports, Volume 11, Issue 9, September 2023., 2023
Microscopic and Immunohistochemistry findings in Castleman Disease. Key Clinical Message Idiopathic Castleman disease transforming into Diffuse Large B‐cell Lymphoma has an aggressive course and can lead to mortality. Hence, early diagnosis and intervention are required.
Ashwini Gupta, Ayush Anand, Salman Haidar Hussain, Raju Shah, Rajesh Ranjan, Viplaw Subedi, Aastha Baral, Akshat Mishra, Anju Pradhan, Soniya Dulal   +9 more
wiley   +1 more source

Comprehensive Diagnosis and Management of POEMS Syndrome

HemaSphere, Volume 6, Issue 11, November 2022., 2022
Polyneuropathy Organomegaly, Endocrinopathy, Monoclonal protein and Skin changes syndrome is a rare multisystem condition with a range of manifestations which are often overlooked as trivial comorbidities, until their whole triggers the possibility of the diagnosis.
Shirley D'Sa, Jahanzaib Khwaja, Stephen Keddie, Ryan YS Keh, Duncan Smyth, Ruth Ronneberger, Suraiya Dubash, Suganya Sivabalasingham, Simon Wan, Chandrashekar Hoskote, Stephanie Baldeweg, Jonathan Sive, Michael P. Lunn   +12 more
wiley   +1 more source

Storming the castle: A case report of multi‐system dysregulation in a child with Castleman disease

Clinical Case Reports, Volume 10, Issue 2, February 2022., 2022
Given the diagnostic complexity and multi‐system organ involvement of Castleman disease, awareness of the clinical presentation in a pediatric patient is important. This can prevent delayed diagnosis and provide timely, life‐saving care. Abstract Castleman disease is a non‐clonal, lymphoproliferative disorder rarely seen in children.
Samantha J. DeMarsh, Nicole E. Kendel, Christine Bacha, Stacy P. Ardoin, Samir Kahwash, Melissa J. Rose   +5 more
wiley   +1 more source

Registry for Angiofollicular Lymph Node Hyperplasia

Annals of Internal Medicine, 1985
To the Editor.— A registry of cases of localized and multicentric angiofollicular lymph node hyperplasia (AFH) has been established at the University of Nebraska Medical Center, Omaha. Localized AFH (Castleman's disease) is thought to be a benign process that occurs as solitary lymphoid mass in young patients (median age, 23.5 years).
D D, Weisenburger, D T, Purtilo
openaire   +5 more sources

Unicentric Castlemans Disease: Unusual Disorder of the Neck a Case Review [PDF]

Journal of Clinical and Diagnostic Research, 2015
Castleman’s disease (giant or angio follicular lymph node hyperplasia) was first described by Benjamin Castleman in the year 1957 and was named after him. It is an uncommon lympho proliferative disorder which is localised to single lymphnode (unicentric)
Renuka S. Melkundi, K.C. Prasad, Roshan R. Jalisatgi, Gautam Swami, Abhilasha Karunasagar   +4 more
doaj   +1 more source

Surgical treatment of unicentric plasma cell histological type Castleman's disease [PDF]

Vojnosanitetski Pregled, 2011
Introduction. Castleman’s disease or angiofollicular lymph hyperplasia is a rare disease with two identified clinical forms. Unicentric or localized form is characterized by isolated growth of lymph nodes, most often in mediastinum, and multicentric ...
Marić Nebojša, Stanić Vojkan, Cvijanović Vlado, Ristanović Aleksandar, Kovačević Snežana, Krivokapić Žarko, Tasić-Radić Olga   +6 more
doaj   +1 more source

Castleman disease of plasma cell type accompanied with bronchiolitis obliterans: a case report and review of the literature

Journal of Medical Case Reports, 2023
Background Castleman disease, also known as giant lymph node hyperplasia or angiofollicular lymph node hyperplasia, is a highly heterogeneous clinicopathological entity that belongs to the family lymphoproliferative disorders.
Qingyuan Zhu, Shuiyou Wang
doaj   +1 more source

Castleman Disease: A Multicenter Case Series from Turkey

Turkish Journal of Hematology, 2022
Objective: Castleman disease (CD) is a rare disease also known as angiofollicular lymph node hyperplasia. The two main histological subtypes are the hyaline vascular and plasma cell variants.
Eren Gündüz, Hakkı Onur Kırkızlar, Elif Gülsüm Ümit, Sedanur Karaman Gülsaran, Vildan Özkocaman, Fahir Özkalemkaş, Ömer Candar, Tugrul Elverdi, Selin Küçükyurt, Semra Paydaş, Özcan Çeneli, Sema Karakuş, Senem Maral, Ömer Ekinci, Yıldız İpek, Cem Kis, Zeynep Tuğba Güven, Aydan Akdeniz, Tiraje Celkan, Ayşe Hilal Eroğlu Küçükdiler, Gülsüm Akgün Çağlıyan, Ceyda Özçelik Şengöz, Ayşe Karataş, Tuba Bulduk, Alper Özcan, Fatma Burcu Belen Apak, Aylin Canbolat, İbrahim Kartal, Hale Ören, Ersin Töret, Gül Nihal Özdemir, Şule Mine Bakanay Öztürk   +31 more
doaj   +1 more source

Transitional type of Castleman's disease manifested as the POEMS syndrome [PDF]

Vojnosanitetski Pregled, 2004
Background. Castleman’s disease is an atypical lymphoproliferative disorder characterized by angiofollicular hyperplasia of lymph nodes. Histologically it can be classified into a hyaline-vascular type, plasma-cell type, and transitional (mixed-cell ...
Tomić Ilija, Plavec Goran, Tasić Olga, Ristanović Aleksandar, Cvijanović Vlado   +4 more
doaj   +1 more source